Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01419197 · BASELINE

Baseline characteristics

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy · Source last updated 2016-10-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      404
    2. group Id
      BG001
      value
      198
    3. group Id
      BG002
      value
      602
    units
    Participants
groups
  1. description
    Trastuzumab emtansine 3.6 mg/kg intravenously every 3 weeks until disease progression (as assessed by the investigator) or unmanageable toxicity.
    id
    BG000
    title
    Trastuzumab Emtansine
  2. description
    Treatment of physician's choice until disease progression (as assessed by the investigator) or unmanageable toxicity. The treatments included single-agent chemotherapy, single-agent or dual-agent hormonal therapy for hormone receptor positive-disease, and HER2-directed therapy.
    id
    BG001
    title
    Treatment of Physician's Choice
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.4
          value
          53.3
        2. group Id
          BG001
          spread
          10.8
          value
          54.3
        3. group Id
          BG002
          spread
          10.5
          value
          53.6
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          401
        2. group Id
          BG001
          value
          197
        3. group Id
          BG002
          value
          598
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          4
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Randomized population: All participants who were randomized to the study.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      404
    2. group Id
      BG001
      value
      198
    3. group Id
      BG002
      value
      602
    units
    Participants
groups
  1. description
    Trastuzumab emtansine 3.6 mg/kg intravenously every 3 weeks until disease progression (as assessed by the investigator) or unmanageable toxicity.
    id
    BG000
    title
    Trastuzumab Emtansine
  2. description
    Treatment of physician's choice until disease progression (as assessed by the investigator) or unmanageable toxicity. The treatments included single-agent chemotherapy, single-agent or dual-agent hormonal therapy for hormone receptor positive-disease, and HER2-directed therapy.
    id
    BG001
    title
    Treatment of Physician's Choice
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.4
          value
          53.3
        2. group Id
          BG001
          spread
          10.8
          value
          54.3
        3. group Id
          BG002
          spread
          10.5
          value
          53.6
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          401
        2. group Id
          BG001
          value
          197
        3. group Id
          BG002
          value
          598
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          4
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Randomized population: All participants who were randomized to the study.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice